The United States continues to call on Cambodia and Thailand to end hostilities, withdraw heavy weapons, cease emplacement of landmines, and fully implement the Kuala Lumpur Peace Accords, which include mechanisms to accelerate humanitarian demining and address border issues. We welcome ASEAN leaders coming together this week to support Cambodia and Thailand fully honoring their commitments to end this conflict.
***THE DAILY PUBLIC SCHEDULE IS SUBJECT TO CHANGE***
SECRETARY MARCO RUBIO
4:30 p.m. Secretary Rubio attends President Trump’s announcement with the Secretary of War and the Secretary of the Navy in Palm Beach, Florida. (MEDIA DETERMINED BY THE WHITE HOUSE)
DEPUTY SECRETARY OF STATE CHRISTOPHER LANDAU
11:15 a.m. Deputy Secretary Landau meets with Kosovo President Vjosa Osmani at the Department of State. (CLOSED PRESS COVERAGE)
DEPUTY SECRETARY OF STATE FOR MANAGEMENT AND RESOURCES MICHAEL J. RIGAS
Deputy Secretary Rigas has no public appointments.
UNDER SECRETARY FOR POLITICAL AFFAIRS ALLISON M. HOOKER
Under Secretary Hooker attends meetings and briefings at the Department of State.
For far too long, the United States spent billions of dollars on global health by writing checks to NGOs and hoping results would follow. Too often, recipient nations had little say, accountability was weak, and only a fraction of that money ever reached patients on the ground. That approach was inefficient, ineffective, and unsustainable. Under President Trump’s leadership, we put a stop to it.
Today, guided by the America First Global Health Strategy, the United States is working directly with sovereign nations – with governments, not intermediaries that impose one-size-fits-all solutions from the outside. This shift has restored accountability, reaffirmed national ownership, and restored America as the world’s global health leader.
In recent weeks, that approach has delivered results at record speed. Since December 4, the United States has signed landmark bilateral health Memorandums of Understanding (MOUs) with Kenya, Rwanda, Liberia, Uganda, Lesotho, Eswatini, Mozambique, Cameroon, and Nigeria. These MOUs represent more than $8 billion in direct U.S. assistance, alongside more than $5 billion in recipient country co-investment, to combat infectious disease threats over the next five years.
These MOUs advance America’s national interest. They save lives, export American health innovation, reduce waste and inefficiency, and coordinate directly with national governments to prevent, detect, and respond to global health threats on their own – making nations less reliant on U.S. taxpayers.
And this is just the beginning. More bilateral health MOUs are on the way as we continue to deliver results, keep our promises, and put American leadership – and American interests – first.
Delivering on President Trump’s Commitment: America First Global Health Strategy and Bilateral Health MOUs
Fact Sheet
December 22, 2025
The Trump Administration is proud to announce historic progress in delivering on the America First Global Health Strategy. In just three months, we have moved with unprecedented speed and focus to conclude a series of landmark bilateral Memorandums of Understanding (MOUs) with recipient countries. These MOUs are proof positive that President Trump’s leadership is making America safer, stronger, and more prosperous — saving millions of lives and helping recipients stand on their own. The United States will continue to build on this momentum, with additional MOUs to be signed in the coming weeks.
Overview of MOUs Signed to Date
Under President Trump’s America First Global Health Strategy, the United States has signed major bilateral health MOUs with Kenya, Rwanda, Liberia, Uganda, Lesotho, Eswatini, Mozambique, Cameroon, and Nigeria — representing more than $8 billion in direct U.S. investment, matched by more than $5 billion in co-investment by recipient countries.
These new MOUs are a game-changer. They maximize the impact of U.S. global health assistance to counter infectious disease threats, strengthen bilateral relationships, and help recipients build resilient, self-reliant health systems – preserving what works in U.S. health foreign assistance while rapidly fixing inefficiencies, reducing dependency, and ensuring that every tax dollar delivers real results for the American people.
Kenya: Supports Kenya’s leadership in charting its own health priorities by shifting more resources into the national system and reducing reliance on NGOs. Invests in data, commodities procurement, and modernization to build sustainable capacity. Incorporates meaningful co-investment commitments from Kenya aligned with ambitious yet realistic performance benchmarks, paving the way for long-term health self-reliance. $2.5 billion (More than $1.6 billion from the United States, more than $850 million from Kenya)
Rwanda: Outlines a comprehensive vision to save lives and strengthen Rwanda’s health system, including by moving away from NGO delivery systems, investing in cutting-edge health care infrastructure, fostering greater national ownership, and positioning Rwanda to take full control of its HIV/AIDS response by year four of the partnership. Builds on the Department’s landmark award to Zipline International Inc. to support the construction of American-made advanced robotics to deliver life-saving medical products. Expands private sector partnership and investment, including developing next generation HIV treatments and deploying artificial intelligence (AI) for healthcare. $228 million (Nearly $158 million from the United States, $70 million from Rwanda)
Liberia: Accelerates Liberia’s transition toward self-reliance and sustainability, saving U.S. taxpayers money and securing long-term health outcomes. Supports critical areas such as HIV/AIDS, malaria, maternal and child health, and global health security. Increases Liberia’s commitment to domestic health expenditures by almost $51 million to assume greater financial and operational responsibility for domestic health systems. $183 million (More than $132 million from the United States, nearly $51 million from Liberia)
Uganda: Invests $1.7 billion in U.S. assistance to combat HIV/AIDs, tuberculosis (TB), malaria, and other infectious diseases while strengthening Uganda’s health system matched by a more than $500 million pledge from Uganda to co-invest in line with the National Development Plan IV and Uganda’s Vision 2040. Furthers Uganda’s national health digitization effort. Provides support for faith-based health care providers and health care services to the Ugandan military. $2.3 billion (More than $1.7 billion from the United States, more than $500 million from Uganda)
Lesotho: Supports Lesotho’s efforts to combat HIV/AIDS, while bolstering the health workforce, data systems, and disease surveillance and outbreak response. Includes $132 million commitment from Lesotho to invest in its domestic HIV/AIDS response. Opens the door to innovation by providing internet connectivity for health clinics, as well as advanced robotics delivery of life-saving medical products. $364 million ($232 million from the United States, $132 million from Lesotho)
Eswatini: Strengthens national health efforts, leverages American technology, and facilitates long-term sustainability of Eswatini’s health system. Improves public health data systems, provides access to HIV antiretroviral medications, scales up access to highly effective HIV prevention interventions, including American-made lenacapavir. Increases Eswatini’s domestic health care expenditures by $37 million. $242 million ($205 million from the United States, nearly $37 million from Eswatini)
Mozambique: Expands access to cutting edge solutions to HIV/AIDS prevention, like lenacapavir. Drives advancements in malaria prevention. Increases Mozambique’s domestic expenditures on healthcare by nearly 30% over five years. Improves maternal, newborn, and child health while increasing national efforts to eliminate mother-to-child transmission of HIV/AIDS. (More than $1.8 billion from the United States, and an increase of 30% in domestic health expenditures by Mozambique)
Cameroon: Funds frontline health commodities and healthcare workers, strengthens laboratory networks, and modernizes data systems with secure interoperable digital tools to enhance disease surveillance and outbreak preparedness. $850 million ($400 million in U.S. assistance and a $450 million commitment from Cameroon)
Nigeria: Strengthens health cooperation and reinforces national long-term leadership of Nigeria’s national health systems. Drives joint action in critical areas such as ensuring reliable access to medicines and affordable integrated health care services that combat HIV/AIDS, tuberculosis (TB), and malaria, while improving maternal and child health outcomes. Invests significant resources in the more than 900 faith-based clinics and hospitals across the country. $5.1 billion (approximately $2.1 billion from the United States, nearly $3 billion from Nigeria)
The maximum duration of these MOUs is five years with no future commitment of U.S. assistance.
Core Elements of Each Bilateral MOU
Each bilateral Memorandum of Understanding reaffirms the United States’ commitment to the ambitious goals that we have set over the past decades for combatting the spread of HIV/AIDS, tuberculosis, malaria, and polio, and prioritizes maternal and child health, disease surveillance, and infectious disease outbreak preparedness. The guiding principles in these MOUs include streamlining performance monitoring, reducing non-frontline investment by integrating U.S. programming within a country’s broader health system, mobilizing the private sector and faith-based organizations, and requiring increased co-investment from receipt countries for healthcare workers and commodities.
Each Memorandum of Understanding also contains important and innovative provisions that facilitate long-term sustainability such as:
Commodities: The procurement of commodities will be transitioned from the U.S. government to partner governments gradually over the period of the MOU. The United States has committed to covering 100 percent of frontline healthcare workers and commodities responsible for U.S. foreign assistance for the next fiscal year and will work with countries to co-invest in these efforts over time.
Frontline Health Workers: Frontline health workers currently funded by the U.S. government will be mapped to the cadres of health workers that can be employed by partner governments, and those cadres of health workers will be transitioned to the partner government payroll over a multi-year period as jointly agreed.
Data Systems: Funding will support the scale up of partner governments’ health data systems to ensure key programmatic data for HIV/AIDS, TB, malaria, polio, and disease outbreaks can be tracked at scale long-term.
Co-Investment: Partner governments will increase their domestic health expenditures over the MOU period, a critical step in ensuring partner governments have the resources they need to sustain their health response long-term without support from the U.S. government.
Performance Incentives: U.S. government financial support will be linked to countries’ ability to meet or exceed key health metrics with financial incentives for countries who exceed those metrics.
President Trump’s America First Global Health Strategy
Launched on September 18, 2025, the America First Global Health Strategy outlines a comprehensive vision to protect Americans from infectious disease threats, strengthen global health systems, and promote American innovation abroad.
The strategy prioritizes bilateral MOUs that transition U.S. technical assistance and key functions to partner governments, mobilize private sector and faith-based organizations, and require increased co-investment from recipient countries.
For far too long, the United States spent billions of dollars on global health by writing checks to NGOs and hoping results would follow. Too often, recipient nations had little say, accountability was weak, and only a fraction of that money ever reached patients on the ground. That approach was inefficient, ineffective, and unsustainable. Under President Trump’s leadership, we put a stop to it.
Today, guided by the America First Global Health Strategy, the United States is working directly with sovereign nations – with governments, not intermediaries that impose one-size-fits-all solutions from the outside. This shift has restored accountability, reaffirmed national ownership, and restored America as the world’s global health leader.
In recent weeks, that approach has delivered results at record speed. Since December 4, the United States has signed landmark bilateral health Memorandums of Understanding (MOUs) with Kenya, Rwanda, Liberia, Uganda, Lesotho, Eswatini, Mozambique, Cameroon, and Nigeria. These MOUs represent more than $8 billion in direct U.S. assistance, alongside more than $5 billion in recipient country co-investment, to combat infectious disease threats over the next five years.
These MOUs advance America’s national interest. They save lives, export American health innovation, reduce waste and inefficiency, and coordinate directly with national governments to prevent, detect, and respond to global health threats on their own – making nations less reliant on U.S. taxpayers.
And this is just the beginning. More bilateral health MOUs are on the way as we continue to deliver results, keep our promises, and put American leadership – and American interests – first.
Announcement of Actions to Combat the Global Censorship-Industrial Complex
Press Statement
December 23, 2025
The State Department is taking decisive action against five individuals who have led organized efforts to coerce American platforms to censor, demonetize, and suppress American viewpoints they oppose. These radical activists and weaponized NGOs have advanced censorship crackdowns by foreign states—in each case targeting American speakers and American companies. As such, I have determined that their entry, presence, or activities in the United States have potentially serious adverse foreign policy consequences for the United States.
Based on these determinations, the Department has taken steps to impose visa restrictions on agents of the global censorship-industrial complex who, as a result, will be generally barred from entering the United States. Further, based on the foreign policy determination, the Department of Homeland Security can initiate removal proceedings against certain individuals pursuant to INA section 237(a)(4)(C), which renders such individuals deportable.
President Trump has been clear that his America First foreign policy rejects violations of American sovereignty. Extraterritorial overreach by foreign censors targeting American speech is no exception. The State Department stands ready and willing to expand today’s list if other foreign actors do not reverse course.
These actions are pursuant to Section 212(a)(3)(C) of the Immigration and Nationality Act, which renders inadmissible any alien whose entry into the Unites States the Secretary of State determines “would have potentially serious adverse foreign policy consequences for the United States.” Certain family members may also be covered by these restrictions. In addition, Section 237(a)(4)(C) of the Immigration and Nationality Act renders an alien deportable from the United States if the Secretary of State has reasonable grounds to believe the alien’s presence or activities in the United States would have potentially serious adverse foreign policy consequences.
Announcement of Actions to Combat the Global Censorship-Industrial Complex
Press Statement
December 23, 2025
The State Department is taking decisive action against five individuals who have led organized efforts to coerce American platforms to censor, demonetize, and suppress American viewpoints they oppose. These radical activists and weaponized NGOs have advanced censorship crackdowns by foreign states—in each case targeting American speakers and American companies. As such, I have determined that their entry, presence, or activities in the United States have potentially serious adverse foreign policy consequences for the United States.
Based on these determinations, the Department has taken steps to impose visa restrictions on agents of the global censorship-industrial complex who, as a result, will be generally barred from entering the United States. Further, based on the foreign policy determination, the Department of Homeland Security can initiate removal proceedings against certain individuals pursuant to INA section 237(a)(4)(C), which renders such individuals deportable.
President Trump has been clear that his America First foreign policy rejects violations of American sovereignty. Extraterritorial overreach by foreign censors targeting American speech is no exception. The State Department stands ready and willing to expand today’s list if other foreign actors do not reverse course.
These actions are pursuant to Section 212(a)(3)(C) of the Immigration and Nationality Act, which renders inadmissible any alien whose entry into the Unites States the Secretary of State determines “would have potentially serious adverse foreign policy consequences for the United States.” Certain family members may also be covered by these restrictions. In addition, Section 237(a)(4)(C) of the Immigration and Nationality Act renders an alien deportable from the United States if the Secretary of State has reasonable grounds to believe the alien’s presence or activities in the United States would have potentially serious adverse foreign policy consequences.
Secretary Rubio’s Call with French Foreign Minister Barrot
Readout
December 23, 2025
The below is attributable to Principal Deputy Spokesperson Tommy Pigott:
Secretary of State Marco Rubio spoke today with French Foreign Minister Jean-Noël Barrot. The Secretary and Foreign Minister discussed the urgent need for a humanitarian ceasefire in Sudan, agreed to continue cooperation on diplomatic efforts to end the Russia-Ukraine war, and agreed to continue implementing President Trump’s peace plan for Gaza.
